Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease

Walters, T.D. (Thomas D.), Faubion, W.A. (William A.), A.M. Griffiths (Anne), R.N. Baldassano (Robert), J.C. Escher (Johanna), F.M. Ruemmele (Frank), J.S. Hyams (Jeffrey), Lazar, A. (Andreas), Eichner, S. (Samantha), Huang, B. (Bidan), et al.

2017-06-01

Inflammatory Bowel Diseases , Volume 23 - Issue 6 p. 967- 975

Additional Metadata
Keywords	adalimumab, anti-TNF antibody, height velocity z-score, linear growth, pediatric Crohn's disease
Persistent URL	doi.org/10.1097/MIB.0000000000001075, hdl.handle.net/1765/100145
Journal	Inflammatory Bowel Diseases
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Walters, T.D. (Thomas D.), Faubion, W.A. (William A.), Griffiths, A., Baldassano, R., Escher, J., Ruemmele, F., … Thakkar, R.B. (Roopal B.). (2017). Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease. Inflammatory Bowel Diseases, 23(6), 967–975. doi:10.1097/MIB.0000000000001075

Publication